Sign In
Buy BETRF
$0.0471
+0.0041 (+9.53%)
At Close: Jun 03, 2026
BetterLife Announces Exercise of Over-Allotment Option in Public Offering
09:51am, Friday, 25'th Jun 2021
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
BetterLife Pharma awarded funding from Mitacs Accelerate program for research on LSD to treat depression
09:27am, Thursday, 24'th Jun 2021
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) announced it has received funding from the Mitacs Accelerate program to research the anti-depressant effects of an LSD derivative. TD-1048A
BetterLife Pharma to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
08:00am, Tuesday, 15'th Jun 2021
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech compan
BetterLife Pharma closes its C$2.6M equity offering
12:15pm, Monday, 07'th Jun 2021
BetterLife Pharma Inc (CSE:BETR) reported it has completed its recently-announced C$2.6 million equity offering, in which it issued 6,525,000 company units at a price of $0.40 per unit. BetterLife s
BetterLife Closes $2.61 Million Marketed Public Offering
10:31am, Monday, 07'th Jun 2021
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
BetterLife Pharma welcomes The Conscious Fund founder Henri Sant-Cassia to its board of directors
10:39am, Wednesday, 02'nd Jun 2021
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) announced it had appointed The Conscience Fund's founder Henri Sant-Cassia to its board of directors. Sant-Cassia is a founding partner of The
BetterLife Pharma to raise up to C$2.6M in a public equity offering
04:51pm, Monday, 31'st May 2021
BetterLife Pharma Inc (CSE:BETR) announced an agreement to raise up C$2.6 million in a marketed public offering of its securities at a price of $0.40 per unit, with Research Capital Corporation acti
BetterLife Announces Marketed Public Offering of Units for up to $2.6 Million
04:17pm, Monday, 31'st May 2021
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
BetterLife Pharma closes bought-deal, over-allotted public offering that raised $6.325M
11:01am, Friday, 28'th May 2021
BetterLife Pharma Inc (CSE:BETR) has closed a bought-deal, over-allotted public offering that raised gross proceeds of $6,325,000. The company said the net proceeds from the offering will be used for
BetterLife Closes $6.325 Million Bought Deal Public Offering of Units, Including Full Exercise of the Over-Allotment Option
09:50am, Friday, 28'th May 2021
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
BetterLife Pharma announces $5.5M bought-deal public offering
08:42am, Friday, 21'st May 2021
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) has announced a $5.5 million bought-deal public offering. In a statement, the company said the net proceeds from the offering will be used f
BetterLife Announces $5.5 Million Bought-Deal Public Offering of Units
07:26pm, Thursday, 20'th May 2021
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
BetterLife Announces Closing of a Non-Brokered Private Placement
08:00am, Friday, 14'th May 2021
VANCOUVER, British Columbia, May 14, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has
BetterLife Pharma files patent protection for an implant designed to mitigate excess psychedelic dosage effects
09:06am, Thursday, 29'th Apr 2021
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) announced that it has applied for patent protection for a novel implant device designed to prevent the potential side effects of patients se
BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs
08:00am, Thursday, 29'th Apr 2021
VANCOUVER, British Columbia, April 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focu
